A Review of Plants Used in the Treatment of Liver Disease: Part 1
作者： Scott Luper
DOI:
关键词: Picrorhiza 、 Fatty liver 、 Silybum marianum 、 Liver disease 、 Picrorhiza kurroa 、 Milk Thistle 、 Medicine 、 Pharmacology 、 Toxic hepatitis 、 Traditional medicine 、 Silybum
摘要: Botanicals have been used traditionally by herbalists and indigenous healers worldwide for the prevention treatment of liver disease. Clinical research in this century has confirmed efficacy several plants Basic scientific uncovered mechanisms which some afford their therapeutic effects. Silybum marianum (milk thistle) shown to clinical applications toxic hepatitis, fatty liver, cirrhosis, ischemic injury, radiation toxicity, viral hepatitis via its antioxidative, anti-lipid peroxidative, antifibrotic, anti-inflammatory, immunomodulating, regenerating Picrorhiza kurroa, though less well researched than Silybum, appears similar action. When compared with hepatoprotective effect was found be similar, or many cases, superior Silybum.
altmedrev.com
anaturalhealingcenter.com 参考文章(140)
Samuel Am, Deshpande Ur, Pillai D, Bhide Sv, Gadre Sg, Raste As, Protective effect of turmeric (Curcuma longa L.) extract on carbon tetrachloride-induced liver damage in rats. Indian Journal of Experimental Biology. ,vol. 36, pp. 573- 577 ,(1998)
Zetl I, Sonnenbichler J, Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers. Progress in Clinical and Biological Research. ,vol. 213, pp. 319- ,(1986)
R Weyhenmeyer, J Birkmayer, H Mascher, Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay. International journal of clinical pharmacology, therapy, and toxicology. ,vol. 30, pp. 134- 138 ,(1992)
I Láng, J Fehér, K Nékám, G Mũzes, P Gergely, R González-Cabello, Hepatoprotective and immunological effects of antioxidant drugs. The Tokai journal of experimental and clinical medicine. ,vol. 15, pp. 123- 127 ,(1990)
G Müzes, J Fehér, K Nékám, G Deák, V Niederland, M Kárteszi, I Láng, [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases]. Orvosi Hetilap. ,vol. 130, pp. 2723- 2727 ,(1989)
S K Acharya, B N Tandon, Y K Joshi, S Dasarathy, A Tandon, A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure. Indian Journal of Medical Research. ,vol. 98, pp. 69- 74 ,(1993)
M. Beaugrand, J. C. Trinchet, C. Gotheil, C. Legendre, V. G. Levy, T. Coste, F. Vivet, V. Duchatelle, [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients]. Gastroenterologie Clinique Et Biologique. ,vol. 13, pp. 120- 124 ,(1989)
G Müzes, J Fehér, K Nékám, G Deák, P Gergely, R Gonzalez-Cabello, V Niederland, I Láng, Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases Orvosi Hetilap. ,vol. 131, pp. 1291- 212956 ,(1990)
G. Basile, A. Apicella, C. Volpe, M. F. Armellino, R. Carducci, N. Caso, V. Basile, Silibinin and acute poisoning with Amanita phalloides Minerva Anestesiologica. ,vol. 62, pp. 187- 193 ,(1996)
O H Weiner, R Weyhenmeyer, E C Fuchs, Effects of silibinin and of a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts. Drug Research. ,vol. 47, pp. 1383- 1387 ,(1997)